Literature DB >> 28431640

Rapid Assessment of Drugs of Abuse.

Joesph R Wiencek1, Jennifer M Colby1, James H Nichols2.   

Abstract

Laboratory testing for drugs of abuse has become standard practice in many settings both forensic and clinical. Urine is the predominant specimen, but other specimens are possible including hair, nails, sweat, and oral fluid. Point-of-care test kits provide for rapid analysis at the site where specimens are collected allowing for immediate action on the results. POCT is based on immunochromatography where the drug in the patient's sample competes with drug and antibody conjugates in the test to develop or block the development of a colored line. Most POCTs are visually interpreted in a few minutes. The potential for false positives is possible due to drug cross-reactivity with the antibodies in the test. False negatives are also possible due to dilution of the sample and the potential for adulteration or sample substitution by the patient. POCT shows more variability than central laboratory testing because of the variety of operators involved in the testing process, but POCT has good agreement for most tests with mass spectrometry provided comparable cutoffs and cross-reactivity of drugs/metabolites are considered. Validation of the test performance with the intended operators will identify potential interferences and operational issues before implementing the test in routine practice. POCT offers faster turnaround of test results provided the limitations and challenges of the test are considered.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug screen; Drug testing; Drugs of abuse; Immunoassay; Near-patient testing; On-site testing; Point-of-care testing; Rapid diagnostics

Mesh:

Substances:

Year:  2016        PMID: 28431640     DOI: 10.1016/bs.acc.2016.11.003

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  3 in total

Review 1.  Combining ecological momentary assessment with objective, ambulatory measures of behavior and physiology in substance-use research.

Authors:  Jeremiah W Bertz; David H Epstein; Kenzie L Preston
Journal:  Addict Behav       Date:  2017-11-16       Impact factor: 3.913

2.  Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute".

Authors:  Marianne Hädener; Tim J Gelmi; Marie Martin-Fabritius; Wolfgang Weinmann; Matthias Pfäffli
Journal:  Int J Legal Med       Date:  2019-01-05       Impact factor: 2.686

3.  Compliance testing of patients in ADHD treatment with lisdexamphetamine (Elvanse®) using oral fluid as specimen.

Authors:  Michael Böttcher; David Kühne; Olof Beck
Journal:  Clin Mass Spectrom       Date:  2019-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.